{"transactions":[{"id":4637243,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-10-07T21:00:30.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":2403,"price":15,"value":36045.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"}],"balance_after":49448,"source":{"system":"sec-edgar","filing":"0001628280-26-065349","document":"wk-form4_1791406827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1977441/000162828026065349/wk-form4_1791406827.xml","form_type":"4"}},{"id":4619202,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-16T20:06:20.000Z","date":"2026-09-15","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":7.081,"value":35405.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.074 to $7.085, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":19310,"source":{"system":"sec-edgar","filing":"0001628280-26-062239","document":"wk-form4_1789589178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026062239/wk-form4_1789589178.xml","form_type":"4"}},{"id":675754,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-08-25T21:01:16.000Z","date":"2026-08-21","kind":"exercise","planned":false,"acquired":false,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":2975,"derivative":{"underlying":"Class A Common Stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0001628280-26-058939","document":"wk-form4_1787691673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026058939/wk-form4_1787691673.xml","form_type":"4"}},{"id":675753,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-08-25T21:01:16.000Z","date":"2026-08-21","kind":"exercise","planned":false,"acquired":false,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":5296,"derivative":{"underlying":"Class A Common Stock","underlying_shares":587},"source":{"system":"sec-edgar","filing":"0001628280-26-058939","document":"wk-form4_1787691673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026058939/wk-form4_1787691673.xml","form_type":"4"}},{"id":675752,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-08-25T21:01:16.000Z","date":"2026-08-24","kind":"sale","planned":false,"acquired":false,"shares":330,"price":6.977,"value":2302.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":51851,"source":{"system":"sec-edgar","filing":"0001628280-26-058939","document":"wk-form4_1787691673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026058939/wk-form4_1787691673.xml","form_type":"4"}},{"id":675751,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-08-25T21:01:16.000Z","date":"2026-08-21","kind":"exercise","planned":false,"acquired":true,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":52181,"source":{"system":"sec-edgar","filing":"0001628280-26-058939","document":"wk-form4_1787691673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026058939/wk-form4_1787691673.xml","form_type":"4"}},{"id":675750,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-08-25T21:01:16.000Z","date":"2026-08-21","kind":"exercise","planned":false,"acquired":true,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":52025,"source":{"system":"sec-edgar","filing":"0001628280-26-058939","document":"wk-form4_1787691673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026058939/wk-form4_1787691673.xml","form_type":"4"}},{"id":700459,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:28:38.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":127423,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."}],"balance_after":127423,"derivative":{"underlying":"Class A Common Stock","underlying_shares":127423},"source":{"system":"sec-edgar","filing":"0001628280-26-051089","document":"wk-form4_1785443315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051089/wk-form4_1785443315.xml","form_type":"4"}},{"id":700458,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:28:38.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":39038,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."}],"balance_after":39038,"derivative":{"underlying":"Class A Common Stock","underlying_shares":39038},"source":{"system":"sec-edgar","filing":"0001628280-26-051089","document":"wk-form4_1785443315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051089/wk-form4_1785443315.xml","form_type":"4"}},{"id":700457,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:28:38.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":117135,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."}],"balance_after":117135,"derivative":{"underlying":"Class A Common Stock","underlying_shares":117135},"source":{"system":"sec-edgar","filing":"0001628280-26-051089","document":"wk-form4_1785443315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051089/wk-form4_1785443315.xml","form_type":"4"}},{"id":700456,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:28:38.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":35736,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."}],"balance_after":35736,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35736},"source":{"system":"sec-edgar","filing":"0001628280-26-051089","document":"wk-form4_1785443315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051089/wk-form4_1785443315.xml","form_type":"4"}},{"id":700780,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:27:21.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":117135,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."}],"balance_after":117135,"derivative":{"underlying":"Class A Common Stock","underlying_shares":117135},"source":{"system":"sec-edgar","filing":"0001628280-26-051087","document":"wk-form4_1785443238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026051087/wk-form4_1785443238.xml","form_type":"4"}},{"id":700779,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:27:21.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":35736,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."}],"balance_after":35736,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35736},"source":{"system":"sec-edgar","filing":"0001628280-26-051087","document":"wk-form4_1785443238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026051087/wk-form4_1785443238.xml","form_type":"4"}},{"id":700778,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:27:21.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":127423,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."}],"balance_after":127423,"derivative":{"underlying":"Class A Common Stock","underlying_shares":127423},"source":{"system":"sec-edgar","filing":"0001628280-26-051087","document":"wk-form4_1785443238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026051087/wk-form4_1785443238.xml","form_type":"4"}},{"id":700777,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:27:21.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":39038,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."}],"balance_after":39038,"derivative":{"underlying":"Class A Common Stock","underlying_shares":39038},"source":{"system":"sec-edgar","filing":"0001628280-26-051087","document":"wk-form4_1785443238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026051087/wk-form4_1785443238.xml","form_type":"4"}},{"id":700455,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:26:21.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":309467,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026."}],"balance_after":309467,"derivative":{"underlying":"Class A Common Stock","underlying_shares":309467},"source":{"system":"sec-edgar","filing":"0001628280-26-051084","document":"wk-form4_1785443178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051084/wk-form4_1785443178.xml","form_type":"4"}},{"id":700454,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-30T20:26:21.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":74258,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027."}],"balance_after":74258,"derivative":{"underlying":"Class A Common Stock","underlying_shares":74258},"source":{"system":"sec-edgar","filing":"0001628280-26-051084","document":"wk-form4_1785443178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051084/wk-form4_1785443178.xml","form_type":"4"}},{"id":705549,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-20T21:00:22.000Z","date":"2026-07-16","kind":"exercise","planned":false,"acquired":false,"shares":312,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":3131,"derivative":{"underlying":"Class A Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0001628280-26-048832","document":"wk-form4_1784581219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026048832/wk-form4_1784581219.xml","form_type":"4"}},{"id":705548,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-07-20T21:00:22.000Z","date":"2026-07-16","kind":"exercise","planned":false,"acquired":false,"shares":1174,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":5883,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1174},"source":{"system":"sec-edgar","filing":"0001628280-26-048832","document":"wk-form4_1784581219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026048832/wk-form4_1784581219.xml","form_type":"4"}},{"id":705547,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-07-20T21:00:22.000Z","date":"2026-07-17","kind":"sale","planned":false,"acquired":false,"shares":752,"price":7.903,"value":5943.056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":51438,"source":{"system":"sec-edgar","filing":"0001628280-26-048832","document":"wk-form4_1784581219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026048832/wk-form4_1784581219.xml","form_type":"4"}},{"id":705546,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-07-20T21:00:22.000Z","date":"2026-07-16","kind":"exercise","planned":false,"acquired":true,"shares":312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":52190,"source":{"system":"sec-edgar","filing":"0001628280-26-048832","document":"wk-form4_1784581219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026048832/wk-form4_1784581219.xml","form_type":"4"}},{"id":705545,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-07-20T21:00:22.000Z","date":"2026-07-16","kind":"exercise","planned":false,"acquired":true,"shares":1174,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":51878,"source":{"system":"sec-edgar","filing":"0001628280-26-048832","document":"wk-form4_1784581219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026048832/wk-form4_1784581219.xml","form_type":"4"}},{"id":737628,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-15T21:05:59.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."}],"balance_after":25000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001628280-26-043299","document":"wk-form4_1781557557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000162828026043299/wk-form4_1781557557.xml","form_type":"4"}},{"id":737327,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":37993,"kind":"person","name":"Fubini Ross","position":1,"cik":"0001868610","reported_name":"Fubini Ross","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-15T21:04:36.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."}],"balance_after":25000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001628280-26-043296","document":"wk-form4_1781557473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026043296/wk-form4_1781557473.xml","form_type":"4"}},{"id":738124,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38258,"kind":"person","name":"Kosuri Sri","position":1,"cik":"0002043887","reported_name":"Kosuri Sri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-15T21:03:33.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."}],"balance_after":25000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001628280-26-043293","document":"wk-form4_1781557411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043887/000162828026043293/wk-form4_1781557411.xml","form_type":"4"}},{"id":737627,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":25806,"kind":"person","name":"SLOAN HARRY","position":1,"cik":"0001258248","reported_name":"SLOAN HARRY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-15T21:02:45.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date."}],"balance_after":25000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001628280-26-043291","document":"wk-form4_1781557362.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258248/000162828026043291/wk-form4_1781557362.xml","form_type":"4"}},{"id":763168,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-05-26T21:04:10.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":3443,"derivative":{"underlying":"Class A Common Stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0001628280-26-038202","document":"wk-form4_1779829445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026038202/wk-form4_1779829445.xml","form_type":"4"}},{"id":763167,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-05-26T21:04:10.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":7057,"derivative":{"underlying":"Class A Common Stock","underlying_shares":587},"source":{"system":"sec-edgar","filing":"0001628280-26-038202","document":"wk-form4_1779829445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026038202/wk-form4_1779829445.xml","form_type":"4"}},{"id":763166,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-05-26T21:04:10.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":307,"price":8.334,"value":2558.538,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":50704,"source":{"system":"sec-edgar","filing":"0001628280-26-038202","document":"wk-form4_1779829445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026038202/wk-form4_1779829445.xml","form_type":"4"}},{"id":763165,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-05-26T21:04:10.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":51011,"source":{"system":"sec-edgar","filing":"0001628280-26-038202","document":"wk-form4_1779829445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026038202/wk-form4_1779829445.xml","form_type":"4"}},{"id":763164,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-05-26T21:04:10.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":50855,"source":{"system":"sec-edgar","filing":"0001628280-26-038202","document":"wk-form4_1779829445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026038202/wk-form4_1779829445.xml","form_type":"4"}},{"id":804244,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-04-20T21:02:42.000Z","date":"2026-04-16","kind":"exercise","planned":false,"acquired":false,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":3599,"derivative":{"underlying":"Class A Common Stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0001628280-26-026038","document":"wk-form4_1776718959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026026038/wk-form4_1776718959.xml","form_type":"4"}},{"id":804243,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-04-20T21:02:42.000Z","date":"2026-04-16","kind":"exercise","planned":false,"acquired":false,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":7644,"derivative":{"underlying":"Class A Common Stock","underlying_shares":587},"source":{"system":"sec-edgar","filing":"0001628280-26-026038","document":"wk-form4_1776718959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026026038/wk-form4_1776718959.xml","form_type":"4"}},{"id":804242,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-20T21:02:42.000Z","date":"2026-04-17","kind":"sale","planned":false,"acquired":false,"shares":324,"price":7.952,"value":2576.448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":50268,"source":{"system":"sec-edgar","filing":"0001628280-26-026038","document":"wk-form4_1776718959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026026038/wk-form4_1776718959.xml","form_type":"4"}},{"id":804241,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-20T21:02:42.000Z","date":"2026-04-16","kind":"exercise","planned":false,"acquired":true,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":50592,"source":{"system":"sec-edgar","filing":"0001628280-26-026038","document":"wk-form4_1776718959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026026038/wk-form4_1776718959.xml","form_type":"4"}},{"id":804240,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-20T21:02:42.000Z","date":"2026-04-16","kind":"exercise","planned":false,"acquired":true,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":50436,"source":{"system":"sec-edgar","filing":"0001628280-26-026038","document":"wk-form4_1776718959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026026038/wk-form4_1776718959.xml","form_type":"4"}},{"id":808574,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-14T21:00:56.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":false,"shares":45553,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 21, 2025, in connection with the Reporting Person's elevation to Chief Financial Officer, the Reporting Person was granted 67,991 PSUs based on a company-wide cash flow reduction\ntarget over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common\nStock reflects actual performance equal to 67% of the company-wide target, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 21, 2025, in connection with the Reporting Person's elevation to Chief Financial Officer, the Reporting Person was granted 67,991 PSUs based on a company-wide cash flow reduction\ntarget over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common\nStock reflects actual performance equal to 67% of the company-wide target, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":45553},"source":{"system":"sec-edgar","filing":"0001628280-26-025107","document":"wk-form4_1776200454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026025107/wk-form4_1776200454.xml","form_type":"4"}},{"id":808573,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-14T21:00:56.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":false,"shares":28368,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 6, 2025, the Reporting Person was granted 45,755 based on a finance team cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31,\n2025.  The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 62% of the finance team target, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 6, 2025, the Reporting Person was granted 45,755 based on a finance team cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31,\n2025.  The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 62% of the finance team target, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":28368},"source":{"system":"sec-edgar","filing":"0001628280-26-025107","document":"wk-form4_1776200454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026025107/wk-form4_1776200454.xml","form_type":"4"}},{"id":808572,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-14T21:00:56.000Z","date":"2026-04-13","kind":"sale","planned":false,"acquired":false,"shares":33171,"price":6.414,"value":212758.794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":49849,"source":{"system":"sec-edgar","filing":"0001628280-26-025107","document":"wk-form4_1776200454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026025107/wk-form4_1776200454.xml","form_type":"4"}},{"id":808571,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-14T21:00:56.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":true,"shares":45553,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":83020,"source":{"system":"sec-edgar","filing":"0001628280-26-025107","document":"wk-form4_1776200454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026025107/wk-form4_1776200454.xml","form_type":"4"}},{"id":808570,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-14T21:00:56.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":true,"shares":28368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":37467,"source":{"system":"sec-edgar","filing":"0001628280-26-025107","document":"wk-form4_1776200454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026025107/wk-form4_1776200454.xml","form_type":"4"}},{"id":809417,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-13T21:00:40.000Z","date":"2026-04-09","kind":"exercise","planned":false,"acquired":false,"shares":251786,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person's spouse was granted 375,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 9, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person's spouse was granted 375,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 9, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":251786},"source":{"system":"sec-edgar","filing":"0001628280-26-024929","document":"wk-form4_1776114037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024929/wk-form4_1776114037.xml","form_type":"4"}},{"id":809416,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-13T21:00:40.000Z","date":"2026-04-10","kind":"sale","planned":false,"acquired":false,"shares":124727,"price":6.434,"value":802493.518,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":436422,"source":{"system":"sec-edgar","filing":"0001628280-26-024929","document":"wk-form4_1776114037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024929/wk-form4_1776114037.xml","form_type":"4"}},{"id":809415,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-13T21:00:40.000Z","date":"2026-04-09","kind":"exercise","planned":false,"acquired":true,"shares":251786,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":561149,"source":{"system":"sec-edgar","filing":"0001628280-26-024929","document":"wk-form4_1776114037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024929/wk-form4_1776114037.xml","form_type":"4"}},{"id":809734,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-13T21:00:11.000Z","date":"2026-04-09","kind":"exercise","planned":false,"acquired":false,"shares":251786,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 375,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 9, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 375,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 9, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":251786},"source":{"system":"sec-edgar","filing":"0001628280-26-024927","document":"wk-form4_1776114009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026024927/wk-form4_1776114009.xml","form_type":"4"}},{"id":809733,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-13T21:00:11.000Z","date":"2026-04-10","kind":"sale","planned":false,"acquired":false,"shares":124727,"price":6.434,"value":802493.518,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":436422,"source":{"system":"sec-edgar","filing":"0001628280-26-024927","document":"wk-form4_1776114009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026024927/wk-form4_1776114009.xml","form_type":"4"}},{"id":809732,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-13T21:00:11.000Z","date":"2026-04-09","kind":"exercise","planned":false,"acquired":true,"shares":251786,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":561149,"source":{"system":"sec-edgar","filing":"0001628280-26-024927","document":"wk-form4_1776114009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026024927/wk-form4_1776114009.xml","form_type":"4"}},{"id":810532,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-10T21:02:14.000Z","date":"2026-04-08","kind":"exercise","planned":false,"acquired":false,"shares":27738,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person's spouse was granted 82,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person's spouse was granted 82,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":27738},"source":{"system":"sec-edgar","filing":"0001628280-26-024745","document":"wk-form4_1775854931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026024745/wk-form4_1775854931.xml","form_type":"4"}},{"id":810531,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-10T21:02:14.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":false,"shares":27738,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person's spouse was granted 82,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person's spouse was granted 82,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":27738,"derivative":{"underlying":"Class A Common Stock","underlying_shares":27738},"source":{"system":"sec-edgar","filing":"0001628280-26-024745","document":"wk-form4_1775854931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026024745/wk-form4_1775854931.xml","form_type":"4"}},{"id":810530,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:02:14.000Z","date":"2026-04-09","kind":"sale","planned":false,"acquired":false,"shares":13116,"price":6.397,"value":83903.052,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":338568,"source":{"system":"sec-edgar","filing":"0001628280-26-024745","document":"wk-form4_1775854931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026024745/wk-form4_1775854931.xml","form_type":"4"}},{"id":810529,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:02:14.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":13155,"price":6.93,"value":91164.15,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":351684,"source":{"system":"sec-edgar","filing":"0001628280-26-024745","document":"wk-form4_1775854931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026024745/wk-form4_1775854931.xml","form_type":"4"}},{"id":810528,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:02:14.000Z","date":"2026-04-08","kind":"exercise","planned":false,"acquired":true,"shares":27738,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":364839,"source":{"system":"sec-edgar","filing":"0001628280-26-024745","document":"wk-form4_1775854931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026024745/wk-form4_1775854931.xml","form_type":"4"}},{"id":810527,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27801,"kind":"person","name":"Shetty Reshma P.","position":1,"cik":"0001873523","reported_name":"Shetty Reshma P.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:02:14.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":true,"shares":27738,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":337101,"source":{"system":"sec-edgar","filing":"0001628280-26-024745","document":"wk-form4_1775854931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873523/000162828026024745/wk-form4_1775854931.xml","form_type":"4"}},{"id":810097,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-10T21:01:54.000Z","date":"2026-04-08","kind":"exercise","planned":false,"acquired":false,"shares":27738,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 82,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 82,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":27738},"source":{"system":"sec-edgar","filing":"0001628280-26-024744","document":"wk-form4_1775854911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024744/wk-form4_1775854911.xml","form_type":"4"}},{"id":810096,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-10T21:01:54.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":false,"shares":27738,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 82,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 82,800 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":27738,"derivative":{"underlying":"Class A Common Stock","underlying_shares":27738},"source":{"system":"sec-edgar","filing":"0001628280-26-024744","document":"wk-form4_1775854911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024744/wk-form4_1775854911.xml","form_type":"4"}},{"id":810095,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:54.000Z","date":"2026-04-09","kind":"sale","planned":false,"acquired":false,"shares":13116,"price":6.397,"value":83903.052,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":338568,"source":{"system":"sec-edgar","filing":"0001628280-26-024744","document":"wk-form4_1775854911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024744/wk-form4_1775854911.xml","form_type":"4"}},{"id":810094,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:54.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":13155,"price":6.93,"value":91164.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":351684,"source":{"system":"sec-edgar","filing":"0001628280-26-024744","document":"wk-form4_1775854911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024744/wk-form4_1775854911.xml","form_type":"4"}},{"id":810093,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:54.000Z","date":"2026-04-08","kind":"exercise","planned":false,"acquired":true,"shares":27738,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":364839,"source":{"system":"sec-edgar","filing":"0001628280-26-024744","document":"wk-form4_1775854911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024744/wk-form4_1775854911.xml","form_type":"4"}},{"id":810092,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27689,"kind":"person","name":"Canton Barry","position":1,"cik":"0001882756","reported_name":"Canton Barry","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:54.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":true,"shares":27738,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":337101,"source":{"system":"sec-edgar","filing":"0001628280-26-024744","document":"wk-form4_1775854911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024744/wk-form4_1775854911.xml","form_type":"4"}},{"id":810091,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-08","kind":"exercise","planned":false,"acquired":false,"shares":212949,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 635,670 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 635,670 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":212949},"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810090,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":false,"shares":212949,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 635,670 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 19, 2025, the Reporting Person was granted 635,670 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 7, 2026 and April 8, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of target performance, as certified by the Compensation Committee of the Board of Directors."}],"balance_after":212949,"derivative":{"underlying":"Class A Common Stock","underlying_shares":212949},"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810089,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-09","kind":"sale","planned":false,"acquired":false,"shares":109767,"price":6.397,"value":702179.499,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":316483,"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810088,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":97015,"price":6.93,"value":672313.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":426250,"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810087,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-08","kind":"exercise","planned":false,"acquired":true,"shares":212949,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":523265,"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":810086,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":27688,"kind":"person","name":"Kelly Jason R","position":1,"cik":"0001845677","reported_name":"Kelly Jason R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-04-10T21:01:36.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":true,"shares":212949,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based restricted stock unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":310316,"source":{"system":"sec-edgar","filing":"0001628280-26-024743","document":"wk-form4_1775854893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026024743/wk-form4_1775854893.xml","form_type":"4"}},{"id":834376,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-18T21:00:24.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":312,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":3755,"derivative":{"underlying":"Class A Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0001628280-26-019475","document":"wk-form4_1773867620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026019475/wk-form4_1773867620.xml","form_type":"4"}},{"id":834375,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-18T21:00:24.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":1174,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":8231,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1174},"source":{"system":"sec-edgar","filing":"0001628280-26-019475","document":"wk-form4_1773867620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026019475/wk-form4_1773867620.xml","form_type":"4"}},{"id":834374,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-03-18T21:00:24.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":708,"price":6.735,"value":4768.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":9099,"source":{"system":"sec-edgar","filing":"0001628280-26-019475","document":"wk-form4_1773867620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026019475/wk-form4_1773867620.xml","form_type":"4"}},{"id":834373,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-03-18T21:00:24.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":9807,"source":{"system":"sec-edgar","filing":"0001628280-26-019475","document":"wk-form4_1773867620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026019475/wk-form4_1773867620.xml","form_type":"4"}},{"id":834372,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-03-18T21:00:24.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":1174,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":9495,"source":{"system":"sec-edgar","filing":"0001628280-26-019475","document":"wk-form4_1773867620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026019475/wk-form4_1773867620.xml","form_type":"4"}},{"id":933048,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-01-22T21:12:16.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":false,"shares":1062,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% vested on January 16, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% vested on January 16, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1062},"source":{"system":"sec-edgar","filing":"0001628280-26-003084","document":"wk-form4_1769116333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026003084/wk-form4_1769116333.xml","form_type":"4"}},{"id":933047,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-01-22T21:12:16.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":false,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":4067,"derivative":{"underlying":"Class A Common Stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0001628280-26-003084","document":"wk-form4_1769116333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026003084/wk-form4_1769116333.xml","form_type":"4"}},{"id":933046,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-01-22T21:12:16.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":false,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":9405,"derivative":{"underlying":"Class A Common Stock","underlying_shares":587},"source":{"system":"sec-edgar","filing":"0001628280-26-003084","document":"wk-form4_1769116333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026003084/wk-form4_1769116333.xml","form_type":"4"}},{"id":933045,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-01-22T21:12:16.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":972,"price":8.917,"value":8667.324,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":8321,"source":{"system":"sec-edgar","filing":"0001628280-26-003084","document":"wk-form4_1769116333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026003084/wk-form4_1769116333.xml","form_type":"4"}},{"id":933044,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-01-22T21:12:16.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":true,"shares":1062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":9293,"source":{"system":"sec-edgar","filing":"0001628280-26-003084","document":"wk-form4_1769116333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026003084/wk-form4_1769116333.xml","form_type":"4"}},{"id":933043,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-01-22T21:12:16.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":true,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":8231,"source":{"system":"sec-edgar","filing":"0001628280-26-003084","document":"wk-form4_1769116333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026003084/wk-form4_1769116333.xml","form_type":"4"}},{"id":933042,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2026-01-22T21:12:16.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":true,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":8075,"source":{"system":"sec-edgar","filing":"0001628280-26-003084","document":"wk-form4_1769116333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026003084/wk-form4_1769116333.xml","form_type":"4"}},{"id":966947,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-16T22:11:04.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":false,"shares":312,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":4223,"derivative":{"underlying":"Class A Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0001628280-25-057441","document":"wk-form4_1765923061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025057441/wk-form4_1765923061.xml","form_type":"4"}},{"id":966946,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-12-16T22:11:04.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":false,"shares":1174,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":9992,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1174},"source":{"system":"sec-edgar","filing":"0001628280-25-057441","document":"wk-form4_1765923061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025057441/wk-form4_1765923061.xml","form_type":"4"}},{"id":966945,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-12-16T22:11:04.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":736,"price":8.886,"value":6540.096,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding\nobligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of\ntax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":7488,"source":{"system":"sec-edgar","filing":"0001628280-25-057441","document":"wk-form4_1765923061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025057441/wk-form4_1765923061.xml","form_type":"4"}},{"id":966944,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-12-16T22:11:04.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":true,"shares":312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":8224,"source":{"system":"sec-edgar","filing":"0001628280-25-057441","document":"wk-form4_1765923061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025057441/wk-form4_1765923061.xml","form_type":"4"}},{"id":966943,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-12-16T22:11:04.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":true,"shares":1174,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":7912,"source":{"system":"sec-edgar","filing":"0001628280-25-057441","document":"wk-form4_1765923061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025057441/wk-form4_1765923061.xml","form_type":"4"}},{"id":1015094,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-10-21T20:56:24.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":false,"shares":1061,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% will vest on January 16, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% will vest on January 16, 2026."}],"balance_after":1062,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1061},"source":{"system":"sec-edgar","filing":"0001977441-25-000010","document":"wk-form4_1761080182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000010/wk-form4_1761080182.xml","form_type":"4"}},{"id":1015093,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-10-21T20:56:24.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":false,"shares":312,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":4535,"derivative":{"underlying":"Class A Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0001977441-25-000010","document":"wk-form4_1761080182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000010/wk-form4_1761080182.xml","form_type":"4"}},{"id":1015092,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-10-21T20:56:24.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":false,"shares":1174,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":11166,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1174},"source":{"system":"sec-edgar","filing":"0001977441-25-000010","document":"wk-form4_1761080182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000010/wk-form4_1761080182.xml","form_type":"4"}},{"id":1015091,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-10-21T20:56:24.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":1312,"price":13.649,"value":17907.488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding\nobligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of\ntax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":6738,"source":{"system":"sec-edgar","filing":"0001977441-25-000010","document":"wk-form4_1761080182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000010/wk-form4_1761080182.xml","form_type":"4"}},{"id":1015090,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-10-21T20:56:24.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":true,"shares":1061,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":8050,"source":{"system":"sec-edgar","filing":"0001977441-25-000010","document":"wk-form4_1761080182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000010/wk-form4_1761080182.xml","form_type":"4"}},{"id":1015089,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-10-21T20:56:24.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":true,"shares":312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":6989,"source":{"system":"sec-edgar","filing":"0001977441-25-000010","document":"wk-form4_1761080182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000010/wk-form4_1761080182.xml","form_type":"4"}},{"id":1015088,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-10-21T20:56:24.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":true,"shares":1174,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":6677,"source":{"system":"sec-edgar","filing":"0001977441-25-000010","document":"wk-form4_1761080182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000010/wk-form4_1761080182.xml","form_type":"4"}},{"id":1023898,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-10-03T21:01:10.000Z","date":"2025-10-01","kind":"sale","planned":false,"acquired":false,"shares":5609,"price":15,"value":84135.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":5503,"source":{"system":"sec-edgar","filing":"0001977441-25-000008","document":"wk-form4_1759525267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000008/wk-form4_1759525267.xml","form_type":"4"}},{"id":1043890,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-10T20:06:35.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":11.06,"value":110600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.97 to $11.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":24310,"source":{"system":"sec-edgar","filing":"0001263805-25-000007","document":"wk-form4_1757534793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000126380525000007/wk-form4_1757534793.xml","form_type":"4"}},{"id":1043889,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":38108,"kind":"person","name":"HENRY CHRISTIAN O","position":1,"cik":"0001263805","reported_name":"HENRY CHRISTIAN O","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-10T20:06:35.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":10.92,"value":109200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.91 to $11.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":34310,"source":{"system":"sec-edgar","filing":"0001263805-25-000007","document":"wk-form4_1757534793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263805/000126380525000007/wk-form4_1757534793.xml","form_type":"4"}},{"id":1055258,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-08-26T20:10:01.000Z","date":"2025-08-21","kind":"exercise","planned":false,"acquired":false,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":4847,"derivative":{"underlying":"Class A Common Stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0001977441-25-000006","document":"wk-form4_1756238998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000006/wk-form4_1756238998.xml","form_type":"4"}},{"id":1055257,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-08-26T20:10:01.000Z","date":"2025-08-21","kind":"exercise","planned":false,"acquired":false,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":12340,"derivative":{"underlying":"Class A Common Stock","underlying_shares":587},"source":{"system":"sec-edgar","filing":"0001977441-25-000006","document":"wk-form4_1756238998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000006/wk-form4_1756238998.xml","form_type":"4"}},{"id":1055256,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-08-26T20:10:01.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":310,"price":12.396,"value":3842.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":11112,"source":{"system":"sec-edgar","filing":"0001977441-25-000006","document":"wk-form4_1756238998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000006/wk-form4_1756238998.xml","form_type":"4"}},{"id":1055255,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-08-26T20:10:01.000Z","date":"2025-08-21","kind":"exercise","planned":false,"acquired":true,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":11422,"source":{"system":"sec-edgar","filing":"0001977441-25-000006","document":"wk-form4_1756238998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000006/wk-form4_1756238998.xml","form_type":"4"}},{"id":1055254,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2025-08-26T20:10:01.000Z","date":"2025-08-21","kind":"exercise","planned":false,"acquired":true,"shares":587,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":11266,"source":{"system":"sec-edgar","filing":"0001977441-25-000006","document":"wk-form4_1756238998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000197744125000006/wk-form4_1756238998.xml","form_type":"4"}},{"id":1083795,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-07-21T20:28:30.000Z","date":"2025-07-16","kind":"exercise","planned":false,"acquired":false,"shares":1061,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% will vest on October 16, 2025; and 25% will vest on January 16, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% will vest on October 16, 2025; and 25% will vest on January 16, 2026."}],"balance_after":2123,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1061},"source":{"system":"sec-edgar","filing":"0001628280-25-035462","document":"wk-form4_1753129687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025035462/wk-form4_1753129687.xml","form_type":"4"}},{"id":1083794,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-07-21T20:28:30.000Z","date":"2025-07-16","kind":"exercise","planned":false,"acquired":false,"shares":312,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter."}],"balance_after":5003,"derivative":{"underlying":"Class A Common Stock","underlying_shares":312},"source":{"system":"sec-edgar","filing":"0001628280-25-035462","document":"wk-form4_1753129687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025035462/wk-form4_1753129687.xml","form_type":"4"}},{"id":1083793,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":19781,"kind":"person","name":"Coen Steven P.","position":1,"cik":"0001977441","reported_name":"Coen Steven P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-07-21T20:28:30.000Z","date":"2025-07-16","kind":"exercise","planned":false,"acquired":false,"shares":1174,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter."}],"balance_after":12927,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1174},"source":{"system":"sec-edgar","filing":"0001628280-25-035462","document":"wk-form4_1753129687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000162828025035462/wk-form4_1753129687.xml","form_type":"4"}}],"next_cursor":"2025-07-21T20:28:30.000000Z,1083793"}